Twelve-month trajectories after inpatient rehabilitation in patients with post-COVID syndrome
Abstract
Introduction:
Post-COVID syndrome commonly manifests with fatigue, cognitive impairment, and psychological symptoms. Although rehabilitation programs are widely used, evidence on long-term...
Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial
Abstract (line breaks added)
Background
It is widely believed that intensive task-specific training enhances neurological...
Receptor-binding autoantibodies are not associated with post-COVID fatigue
Achleitner; Dänhardt; Kardashi; Toepfner; de With; Li; Jarzebska; Rodionov; Bornstein; Steenblock
Persistent fatigue is a common symptom following SARS-CoV-2 infection, but its underlying mechanisms remain incompletely...
Low Dose Naltrexone for Post-COVID Fatigue Syndrome: A Randomized Controlled Trial
OBJECTIVES
To assess the efficacy and safety of low-dose naltrexone (LDN) for reducing fatigue severity at 16 weeks in persons with post-COVID fatigue syndrome (PCFS).
DESIGN
Decentralized, randomized, parallel...
Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany: the PreVitaCOV randomised clinical trial
Summary
Background
Post-COVID-19 syndrome is burdensome and not yet adequately treatable, with persistent symptoms including fatigue, dyspnoea, and cognitive impairment.
The...
No evidence of hypercoagulability, altered fibrinolysis, or increased fibrin(ogen) microaggregates in never‐hospitalized long COVID
Last paragraph
In summary, in never-hospitalized patients with specialist-confirmed LC, we found no evidence of persistent prothrombotic activation, impaired...
Resting-State Functional Connectivity and Cognitive Performance in Long COVID: A Randomized Controlled Trial
David O’Connor; Eric Watson; David L Reich; Fernando Carnavali; Megan Mcveety; Pranav Gwalani; Juan P Wisnivesky; Jacqueline H Becker
Cognitive impairment is a prevalent, disabling...
Exploratory clinical and immunological changes following Tixagevimab/Cilgavimab administration in immunodeficient patients with SARS-CoV-2-associated ME/CFS and persistent circulating spike protein
Seidel; Anft; Wiemers; Seibert; Bertram; Rosiewicz; Stervbo; Westhoff; Babel
BACKGROUND...
Effectiveness of tailored individual follow-up vs. standard one-day group course on health-related quality of life in patients with post COVID-19 condition: a randomized controlled trial
Wilson, Marte; Michalsen, Henriette; Anke, Audny; Pedersen, Synne G; Espinasse, Marina; Langeland, Nina; Cox...
Effects of specialized pro-resolving mediators and telerehabilitation on fatigue, dyspnea, and quality of life in post‑COVID‑19 condition: the ARACOV-02 randomized controlled trial
Abstract
Background
Post‑COVID‑19 Condition (PCC) is characterized by persistent multisystem symptoms, with...
Immunoglobulin Replacement Does Not Correlate With Overall Improvement in Post-Acute Sequelae of COVID-19 Symptoms
Rationale
Immunoglobulin (Ig) replacement therapy is a current treatment for patients with certain immune deficiencies. Multiple pathophysiologic mechanisms have indicated the...
Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial
Abstract
Background
Gut microbiota composition might have a role in the pathogenesis of irritable bowel syndrome (IBS), and faecal microbiota transplantation...
Full title: Efficacy and safety of rozanolixizumab in severe fibromyalgia: a phase 2A randomised, double-blind, placebo-controlled, multicentre trial
Background
Fibromyalgia is a chronic disorder characterised by widespread pain, fatigue, sleep disturbances, and cognitive dysfunction. Evidence...
Nirmatrelvir–ritonavir targeting viral persistence in post-COVID-19 condition long COVID in the USA RECOVER-VITAL: a randomised, double-blind, placebo-controlled, phase 2 trial
Lindsey R Baden + 253 others
BACKGROUND
Post-acute sequelae of SARS-CoV-2 infection, more commonly known as long...
Symptom Response to Low-Dose Naltrexone in Fibromyalgia: An Exploratory Analysis of the Randomized Placebo-Controlled FINAL Trial
Nielsen, Maria Juul; Vaegter, Henrik Bjarke; Bruun, Karin Due
Abstract
Background: Fibromyalgia (FM) remains difficult to manage due to a highly variable symptom...
Impact of immunoadsorption on autoantibodies and physical performance in post-COVID patients: a prospective exploratory study of 18 participants
PURPOSE
Autoantibodies against β-adrenergic and muscarinic acetylcholine receptors are said to play a role in the pathophysiology of post-COVID...
Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: a randomized double-blind placebo-controlled pilot trial
Background
Long COVID is heterogeneous and currently without cure. The disease resembles myalgic encephalomyelitis/chronic fatigue syndrome...
Additional effects of group training and online exercise to a 12-week online pacing and education module on health-related quality of life in adult patients with post COVID-19: a randomized controlled trial
Gartemann, Sophie; Luedtke, Kerstin
Abstract
This study assessed the effectiveness of a...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.